financetom
Business
financetom
/
Business
/
Soccer-Garnacho out of Argentina squad with knee problem
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Soccer-Garnacho out of Argentina squad with knee problem
Oct 7, 2024 9:57 AM

Oct 7 (Reuters) - Argentina forward Alejandro Garnacho will miss their World Cup qualifiers against Venezuela and Bolivia due to discomfort in his left knee, the team said on Monday.

The 20-year-old Manchester United ( MANU ) winger completed Sunday's 0-0 draw against Aston Villa in the Premier League but will not join up with the Argentina squad.

Argentina, who lead the standings on 18 points from eight games, visit sixth-placed Venezuela on Thursday and host Bolivia, who are eighth, next Tuesday.

Garnacho was initially called up for the two games, but coach Lionel Scaloni has now replaced him with Leicester City's Facundo Buonanotte.

Garnacho has seven caps and played in the Copa America in the U.S. where Argentina clinched a record 16th title in July.

Argentina squad:

Goalkeepers: Geronimo Rulli, Juan Musso and Walter Benitez.

Defenders: Gonzalo Montiel, Nahuel Molina, Cristian Romero, Leonardo Balerdi, German Pezzella, Nicolas Otamendi, Lisandro Martinez, Marcos Acuna, Nicolas Tagliafico and Julio Soler.

Midfielders: Leandro Paredes, Alexis Mac Allister, Rodrigo De Paul, Exequiel Palacios, Enzo Fernandez, Giovani Lo Celso, Thiago Almada and Facundo Buonanotte.

Forwards: Nicolas Paz, Lionel Messi, Lautaro Martínez, Julian Alvarez and Valentín Carboni

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Is Dyne Therapeutics Stock Soaring On Monday?
Why Is Dyne Therapeutics Stock Soaring On Monday?
May 20, 2024
Monday, Dyne Therapeutics Inc ( DYN ) released clinical data from its ongoing Phase 1/2 ACHIEVE trial of DYNE-101 in patients with myotonic dystrophy type 1 (DM1) and its ongoing Phase 1/2 DELIVER trial of DYNE-251 in patients with Duchenne muscular dystrophy (DMD) who are amenable to exon 51 skipping.  Earlier this year, Dyne Therapeutics ( DYN ) released initial clinical data from both trials. In...
--Chemed Maintains Quarterly Dividend at $0.40 Per Share, Payable June 18 to Shareholders of Record on May 30
--Chemed Maintains Quarterly Dividend at $0.40 Per Share, Payable June 18 to Shareholders of Record on May 30
May 20, 2024
03:52 PM EDT, 05/20/2024 (MT Newswires) -- Price: 562.72, Change: -2.80, Percent Change: -0.50 ...
Bunge's Brazil gradually resuming operations in Rio Grande
Bunge's Brazil gradually resuming operations in Rio Grande
May 20, 2024
SAO PAULO, May 20 (Reuters) - The Brazilian unit of U.S.-based grain trader Bunge said on Monday it is gradually resuming operations in the town of Rio Grande, where it operates a port terminal and a soy crushing unit in southern Brazil. Grain reception and loading operations at Bunge's Rio Grande port has resumed while its local soy crushing unit...
US ITC probes ArcelorMittal complaint that VinFast violated aluminum patents
US ITC probes ArcelorMittal complaint that VinFast violated aluminum patents
May 20, 2024
WASHINGTON, May 20 (Reuters) - The U.S. International Trade Commission said Monday it is investigating a complaint filed by ArcelorMittal that Vietnamese automaker VinFast violated its patents related to high-strength aluminum and aluminum alloy-coated steel in imported vehicles. ArcelorMittal in April filed a complaint with the ITC and also filed suit against VinFast in U.S. District Court in California, accusing...
Copyright 2023-2026 - www.financetom.com All Rights Reserved